Results 191 to 200 of about 7,612 (209)
Some of the next articles are maybe not open access.
Cytotoxic Effect of Binar Cisplatin Immunoconjugate
1998Increasing the effeciency of antitumoral therapy is connected, to a considerable degree, with creating and using perspective forms of antitumor preparations of a purposeful action. Platinum preparations relate to the effective group of cytostatic compounds, inhibitors of tumor and leukemic cell proliferation.
openaire +2 more sources
Immunoconjugates as Anti-Cancer Agents
1998In general, drug design in cancer therapy tends to focus on inhibiting cell growth. In cancer cells, there is abnormal growth activity which is often correlated with the high activity of certain proteins in the tumour cells. If such proteins can be identified and their role in cell growth verified, then limiting their activity by binding an inhibitor ...
Richard Pauptit +4 more
openaire +1 more source
Immunoconjugate Therapy of Hematologic Malignancies
19931. Radioimmunotherapy of Lymphoma T.M. Kuzel, S.T. Rosen. 2. High Dose Radioimmunotherapy of Lymphomas O. Press, J. Eary, C. Badger, F. Applebaum, G. Wiseman, D. Matthews, P. Martin, I. Bernstein. 3. The Treatment of Leukemia with Radiolabeled Monoclonal Antibodies G. Sgouros, D. Scheinberg. 4. New Approaches to Radiolabeling Monoclonal Antibodies A.M.
openaire +1 more source
Genetically engineered immunoconjugates
Nuclear Medicine Communications, 1993openaire +2 more sources
Monoclonal antibody immunoconjugates for cancer treatment
Current Opinion in Immunology, 1989R W, Baldwin, V S, Byers
openaire +2 more sources